Company Filing History:
5 out of 9 
2 out of 10 
1 out of 25 
Years Active: 2012-2021
Title: Brenton Skylar Wolfe: Innovator in Pharmaceutical Development
Introduction
Brenton Skylar Wolfe is a notable inventor based in West Lafayette, Indiana, recognized for his contributions to pharmaceutical innovations. With a total of nine patents to his name, Wolfe has made significant strides in the field of drug development, particularly in treating various medical conditions.
Latest Patents
Wolfe's latest patents focus on crystalline solvate forms of a pharmaceutical compound known as 17α-ethynylandrost-5-ene-3β,7β,17β-triol. These patents describe both amorphous and crystalline forms, as well as specific polymorphic forms of the compound. The applications of this compound are extensive, targeting hyperglycemic conditions such as type 2 diabetes and metabolic syndrome, autoimmune conditions like rheumatoid arthritis and ulcerative colitis, and neurodegenerative disorders. Additionally, his patents detail treatment methods using solid state forms of the compound, including formulations for both solid and suspension forms, which are designed to effectively address the aforementioned health issues.
Career Highlights
Throughout his career, Wolfe has worked with several companies, including Neurmedix, Inc. and Harbor Therapeutics, Inc. His work has been instrumental in advancing pharmaceutical formulations that aim to improve patient outcomes in various medical conditions.
Collaborations
Wolfe has collaborated with notable professionals in the field, including Steven K. White and Igor Ivanisevic. These partnerships have contributed to the development and refinement of his innovative pharmaceutical solutions.
Conclusion
Brenton Skylar Wolfe's contributions to pharmaceutical innovation are significant, with a focus on developing treatments for critical health conditions. His work continues to impact the medical field positively, showcasing the importance of innovation in improving patient care.